Anixa Biosciences, Inc.ANIXNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-6.88M
↓ 18% vs avg
Percentile
P13
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-5.83M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-6.88M | +4.1% |
| 2025 | $-7.17M | +2.2% |
| 2024 | $-7.33M | -18.1% |
| 2023 | $-6.21M | +4.4% |
| 2022 | $-6.49M | -31.5% |
| 2021 | $-4.94M | +20.2% |
| 2020 | $-6.19M | -25.9% |
| 2019 | $-4.92M | -14.0% |
| 2018 | $-4.31M | -12.7% |
| 2017 | $-3.83M | - |